Spyre Therapeutics IBD Drug Shows Promise in Early-Stage Trial
Spyre Therapeutics' inflammatory bowel disease therapy succeeded in its first major clinical testing, setting up competition with several large pharmaceutical companies in the IBD space.
·1 source
